Abstract:Introduction: Sleep disruption affects biological processes that facilitate carcinogenesis. This retrospective cohort study used de-identified data from the Veterans Administration (VA) electronic medical record system to test the hypothesis that patients with diagnosed sleep disorders had an increased risk of prostate, breast, colorectal, or other cancers (1999-2010, N=663,869). This study builds upon existing evidence by examining whether patients with more severe or longer-duration diagnoses were at a greater risk of these cancers relative to those with a less severe or shorter duration sleep disorder. Methods: Incident cancer cases were identified in the VA Tumor Registry and sleep disorders were defined by International Classification of Sleep Disorder codes. Analyses were performed using extended Cox regression with sleep disorder diagnosis as a time-varying covariate. Results: Sleep disorders were present among 56,055 eligible patients (8% of the study population); sleep apnea (46%) and insomnia (40%) were the most common diagnoses. There were 18,181 cancer diagnoses (41% prostate, 12% colorectal, 1% female breast, 46% other). The hazard ratio (HR) for a cancer diagnosis was 1.45 (95% confidence interval [CI]: 1.37, 1.54) among those with any sleep disorder, after adjustment for age, sex, state of residence, and marital status. Risks increased with increasing sleep disorder duration (short [ 2-5 years] 1.23 [1.16-1.32]; long [>5-12 years] 1.52 [1.34-1.73]). Risks also increased with increasing sleep disorder severity using cumulative sleep disorder treatments as a surrogate exposure; African Americans with more severe disorders had greater risks relative to those with fewer treatments and other race groups. Results among patients with only sleep apnea, insomnia, or another sleep disorder were similar to those for all sleep disorders combined. Discussion: The findings are consistent with other studies indicating that sleep disruption is a cancer risk factor. Optimal sleep and appropriate sleep disorder management are modifiable risk factors that may facilitate cancer prevention.

Sleep Disruption and Cancer: Chicken or the Egg?

Melatonin, sleep disturbance and cancer risk

Circadian, hormonal, and sleep rhythms: effects on cancer progression implications for treatment

Circadian disruption and cancer- and treatment-related symptoms

Oxidative stress, cancer, and sleep deprivation: is there a logical link in this association?

Sleep disorders and cancer incidence: examining duration and severity of diagnosis among veterans

Eyes wide open: Sleep as a potential contributor to racial and ethnic disparities in cancer

Circadian rhythm disrupting behaviours and cancer outcomes in breast cancer survivors: a systematic review

Circadian rhythms and cancers: the intrinsic links and therapeutic potentials

Impact of sleep on gastrointestinal cancer

Sleep Characteristics and Cancer-Related Outcomes: an Umbrella Review of Systematic Reviews and Meta-Analyses of Observational Studies

Circadian Rhythm Disruption in Cancer Survivors: From Oncogenesis to Quality of Life

Disrupting circadian rhythms promotes cancer-induced inflammation in mice

Obstructive Sleep Apnea Promotes Cancer Development and Progression: a Concise Review

Characteristics and correlates of sleep disturbances in cancer patients

Sleep and gynecological cancer outcomes: opportunities to improve quality of life and survival

Long-term and Short-term Effects of Insomnia in Cancer and Effective Interventions

Why Do Our Cancer Patients Sleep So Badly? Sleep Disorders in Cancer Patients: A Frequent Symptom with Multiple Causes

Disrupted Sleep: From Molecules to Cognition

The Impact of Immunotherapy on Sleep and Circadian Rhythms in Patients with Cancer

Associations of sleep disorders with all-cause and cause-specific mortality in cancer survivors: a cross-sectional analysis of the NHANES 2005–2016